TruAlt Bioenergy Surges on Strong Q3, Eyes SAF and CBG Growth

RENEWABLES
Whalesbook Logo
AuthorRiya Kapoor|Published at:
TruAlt Bioenergy Surges on Strong Q3, Eyes SAF and CBG Growth
Overview

TruAlt Bioenergy posted a stellar Q3 FY26 with revenue jumping 71.8% YoY to ₹713.24 Cr and a significant profit turnaround from a net loss of ₹491.75 Cr to a profit of ₹863.91 Cr for the nine months. The company also announced strategic partnerships for Compressed Biogas (CBG) plants with Sumitomo and Sustainable Aviation Fuel (SAF) production with Honeywell, signaling diversification and future growth potential. However, management cautioned that Q3 results may not reflect full-year performance due to business seasonality and ongoing operational adjustments.

📉 The Financial Deep Dive

TruAlt Bioenergy Limited has staged a remarkable comeback, reporting a significant turnaround in its financial performance for the third quarter of fiscal year 2026. Consolidated revenue from operations soared by 71.8% year-on-year to ₹713.24 Cr, a substantial leap from ₹415.11 Cr in Q3 FY25. Quarter-on-quarter, revenue also saw the same 71.8% increase, indicating strong recent momentum.

More critically, the company reversed substantial losses into significant profits. For Q3 FY26, TruAlt Bioenergy posted a net profit attributable to shareholders of ₹896.83 Cr. This contrasts sharply with a net loss of ₹491.75 Cr in Q3 FY25 and a loss of ₹494.30 Cr in Q2 FY26. The Earnings Per Share (EPS) mirrored this turnaround, moving from a loss of ₹5.37 in Q3 FY25 to a positive ₹10.65 in Q3 FY26.

For the nine months ended December 31, 2025, revenue grew by 13.1% to ₹1,131.99 Cr. Net profit for this period also saw a robust increase of 86.8% to ₹863.91 Cr, with EPS climbing to ₹10.25 from ₹4.95 in the prior year.

🚩 Risks & Outlook

Despite the strong quarterly results, management issued a cautionary note regarding the nine-month performance not being fully representative of the full year. This is attributed to the inherent seasonality in the ethanol business, tied to sugarcane crop cycles. Furthermore, ongoing dual-feed capability conversions at several units and Unit 5 remaining non-operational pending its Consent to Operate (CTO) have impacted capacity utilization. Unit 1 became operational only in November 2025.

Strategically, the company is making bold moves. A joint venture with Sumitomo Corporation for a 49% stake in TruAlt Gas Private Limited is set to drive compressed biogas (CBG) plant development, with construction underway at three of five planned locations. Additionally, an agreement with Honeywell to deploy Ethanol-to-Jet (ETJ) technology for a Sustainable Aviation Fuel (SAF) production facility (targeting 80,000 tonnes per annum) signifies a significant diversification into the high-growth renewable fuels market.

The appointment of Mr. Monu Kumar as Company Secretary adds to governance oversight. Investors will closely watch the operational ramp-up of Unit 1, the commissioning of CBG plants, and the execution of the SAF project against potential seasonal headwinds and regulatory approvals.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.